Mercury and vaccines
Washington state's Secretary of Health Mary Selecky: fraudulent,
misquoted, or uninformed?
by Teresa Binstock
Sep 30, 2009
Once again, a highly placed public figure has presented a misleading or
inaccurate statement wherein thimerosal is erroneously described as harmless.
In an article about thimerosal in swine flu shots, reporter Sandi Doughton's
summarized Washington Health Department's Secretary of Health Mary Selecky as
having said, "The preservative, thimerosal, has never been linked to any health
Is Mary Selecky playing word games that differentiate between health problems
and, in contrast, thimerosal-induced developmental delays? Is she not aware of
peer-reviewed findings which describe associations between thimerosal injections
and developmental disabilities?
Conclusions in several studies prompt concern (a) for Sandi Daughton's reporting
of what Mary Selecky said, or (b) for Mary Selecky said.
Consider several studies. Male infants who received thimerosal-containing
hepatitis-B vaccinations were nine times as likely to be receiving special
education services (2) and were three times as likely to have developed autism
(3). These findings have been supported by results of a newly published study
wherein infant primates injected with thimerosal-containing hepatitis B vaccines
manifested developmental delays (4). A synopsis of the new study and delineation
of other findings about thimerosal injections' adverse effects has been written
by Mark Blaxill (5).
Questions: Was Mary Selecky misquoted? If not, and if she is aware of
thimerosal's adverse effects and was accurately quoted as saying "no health
effects", ought she be removed from her position within the Washington Health
Department? If she is not aware of the studies cited herein, then her
thimerosal statement reported by Sandi Doughton was rooted in Ms. Selecky's
ignorance and a correction ought be issued by Mary Selecky and the Health
Given various "experts" false assurances (eg, 6) about thimerosal's safety (when
findings suggest quite the opposite) relevant questions include, Who profits
from increased numbers of vaccinations delivered? And, who profits from
increased numbers of children with developmental disabilities?
1. State lifts limit on mercury preservative in
By Sandi Doughton
Seattle Times science reporter
In preparation for swine-flu vaccinations next month, Washington's Health
Department on Thursday temporarily suspended a rule that limits the amount of a
mercury preservative in vaccines given to pregnant women and children under the
age of 3.
The preservative, thimerosal, has never been linked to any health problems, said
Secretary of Health Mary Selecky. But a vocal minority believes the compound
could be linked to autism. The state Legislature adopted the limit in 2006.
Thimerosal has been eliminated from most vaccines in the United States, but it
will be added to the bulk of the swine-flu vaccine being produced to stem a
pandemic that health officials estimate could sicken more than a third of the
2. Hepatitis B triple series vaccine and
developmental disability in US children aged 1-9 years
Gallagher C, Goodman M. Toxicol Environ Chem 2008
3. Hepatitis B vaccination of male neonates and
CM Gallagher, MS Goodman
Annals of Epidemiology
Vol. 19, No. 9 ABSTRACTS (ACE)
September 2009: p. 659
Stony Brook University Medical Center, NY
PURPOSE: Universal newborn immunization with hepatitis B vaccine was recommended
in 1991; however, safety findings are mixed. The Vaccine Safety Datalink
Workgroup reported no association between hepatitis B vaccination at birth and
febrile episodes or neurological adverse events. Other studies found positive
associations between hepatitis B vaccination and ear infection, pharyngitis, and
chronic arthritis; as well as receipt of early intervention/special education
services (EIS); in probability samples of
U.S. children. Children with autistic spectrum disorder (ASD) comprise a growing
caseload for EIS. We evaluated the association between hepatitis B vaccination
of male neonates and parental report of ASD.
METHODS: This cross-sectional study used U.S. probability samples obtained from
National Health Interview Survey 1997–2002 datasets. Logistic regression
modeling was used to estimate the effect of neonatal hepatitis B vaccination on
ASDrisk amongboys age 3–17 years with shot records, adjusted for race, maternal
education, and two-parent household.
RESULTS:Boyswho received the hepatitis B vaccine during the first month of life
had 2.94 greater odds for ASD (nZ31 of 7,486; OR Z 2.94; p Z 0.03; 95% CI Z
1.10, 7.90) compared to later- or unvaccinated boys. Non-Hispanicwhite boys were
61% less likely to have ASD(ORZ0.39; pZ0.04; 95% CIZ0.16, 0.94) relative to
CONCLUSION: Findings suggest that U.S. male neonates vaccinated with hepatitis B
vaccine had a 3-fold greater risk of ASD; risk was greatest for non-white boys.
4. Delayed Acquisition of Neonatal Reflexes in
Newborn Primates Receiving a Thimerosal-Containing Hepatitis B Vaccine:
Influence of Gestational Age and Birth Weight
Hewitson L et al.
NeuroToxicology, In Press, Accepted Manuscript, Available online 30 September
5. [Synopsis & review]
Blockbuster primate Study Shows Significant Harm
from One Birth Dose of a Mercury-containing Vaccine
By Mark Blaxill; Sept 30, 2009
6. Did NIAID's Anthony Fauci commit fraud or did US
News & World Report misquote Dr. Fauci?
Teresa Binstock, Aug 29, 2009